Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-002937

10% owner bought 30,000 shares at an average $4.53 ($135,800)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-02-03 Purchase +17,500 $4.65 $81,375 5,145,786 D: show line 1 in the form
Cambrian BioPharma Inc 10% owner 2022-02-04 Purchase +2,500 $4.45 $11,125 5,148,286 D: show line 2 in the form
Cambrian BioPharma Inc 10% owner 2022-02-08 Purchase +10,000 $4.33 $43,300 5,158,286 D: show line 3 in the form
Open-market purchases · 30,000 sh · avg $4.53 · $135,800
Loading xslF345X03/doc1.xml…